MedTrace Logo

The Impact of Routine Follow-up Contacts After a Pediatric ED Visit for Youth With Suicide Risk

NCT06616701 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 401

Last updated 2025-07-25

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a social work led follow up program helps caregivers of youths with suicide risk access mental health resources.

Primary aims include:

1. To formalize a mental health follow up protocol that assists youths with engagement of mental health services after a hospital visit.
2. To evaluate and standardize the optimal timing for the follow up phone calls.
3. To assess the proportion of patients with suicide risk who connect with community mental health care within a month after a pediatric emergency department (ED) visit at Johns Hopkins Hospital.
4. To assess the proportion of patients with suicide risk who have repeat ED visits within 3 and 6 months.

The primary outcome of interest is the proportion of youths referred to a community provider who successfully connect to community mental health resources 5 to 10 business days after an ED visit. The secondary outcome will involve repeat ED visits within 3 and 6 months.

Conditions

Interventions

BEHAVIORAL

Follow up call

As part of the standard of care, caregivers of youths who present to the hospital with suicidal risk receive a follow up call approximately 5-10 business days after the hospital discharge to assist them with any challenges they may encounter in accessing mental health care, including medication access. The intervention group will receive a call 5 days after discharge. The non-intervention group will receive a call 10 days after discharge.

Sponsors & Collaborators

Principal Investigators

  • Hanae Fujii-Rios, MD MPH · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-20
Primary Completion
2024-11-20
Completion
2025-05-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06616701 on ClinicalTrials.gov